v3.26.1
Share-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2026
Restricted Shares  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Summary of Stock Compensation Expense The following table summarizes restricted stock compensation expense for the periods presented:

 

 

Six Months Ended June 30,

 

 

 

2026

 

 

2025

 

Total share-based compensation - restricted stock

 

$

4,612

 

 

$

4,377

 

Income tax benefit

 

 

1,210

 

 

 

1,166

 

Unrecognized compensation expense

 

 

15,247

 

 

 

14,391

 

Weighted average remaining amortization period

 

2.1 Years

 

 

2.1 Years

 

Performance Share  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Summary of fair value of the total stock return performance-based awards granted The fair value of the total stock return performance-based awards granted in 2026 and 2025 were calculated based on a Monte Carlo simulation, using the following assumptions:

 

 

Performance Based Grants

 

 

 

2026

 

 

2025

 

Risk-free interest rate

 

 

3.47

%

 

 

4.15

%

Expected term (years)

 

2.85 years

 

 

2.85 years

 

Expected stock price volatility

 

29.44% - 33.66%

 

 

30.01% - 34.52%

 

Weighted average grant date fair value

 

$

32.97

 

 

$

28.32

 

 

Two Thousand Seventeen Omnibus Plan  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Summary of Changes in Restricted Shares

The following table discloses the changes in restricted shares for the six months ended June 30, 2026:

 

 

Omnibus Plans

 

 

 

Number of Shares

 

 

Weighted Average
Grant Date Fair
Value

 

Beginning balance, January 1, 2026

 

 

744,038

 

 

$

25.12

 

Granted

 

 

307,366

 

 

 

33.10

 

Incremental performance shares issued and vested

 

 

18,424

 

 

 

 

Vested

 

 

(364,254

)

 

 

24.95

 

Forfeited

 

 

(6,960

)

 

 

29.11

 

Ending balance outstanding at June 30, 2026

 

 

698,614

 

 

$

28.68

 

FEB Plan  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Summary of Activity in shares Subjected to Options and Weighted Average Exercise Prices

The following table discloses the activity in shares subject to options under the FEB Plan and the weighted average exercise prices, in actual dollars, for the six months ended June 30, 2026:

 

 

FEB Plan

 

 

 

Number of Shares

 

 

Weighted Average Exercise Price

 

 

Intrinsic
Value

 

 

Weighted Average Remaining Contractual Term (in Years)

 

Beginning balance, January 1, 2026

 

 

27,119

 

 

$

12.70

 

 

$

446

 

 

 

1.0

 

Exercised

 

 

(10,867

)

 

$

12.70

 

 

$

224

 

 

 

 

Expired

 

 

 

 

 

 

 

 

 

 

 

 

Ending balance outstanding at June 30, 2026

 

 

16,252

 

 

$

12.70

 

 

$

406

 

 

 

0.5

 

Exercisable at June 30, 2026

 

 

16,252

 

 

$

12.70

 

 

$

406

 

 

 

0.5